This product is used for the treatment of colicky pain in biliary
and urinary tract, bladder tenesmus, painful spasms in the stomach
and intestines, spastic dysmenorrhea, and control of spastic pain
during and after instrumental examination.
Analgin passes the placental barrier, and should there fore be used
during pregnancy, especially during the first 3 rnonths and the
last 6 weeks, only after careful consideration of the indications.
Analgin was considered to be unsafe in patients with acute
Analgin produced an exacerbation of dyspnoea, cyanosis and
Agranulocytosis presumed to be due to Analgin Allergic skin
Administration: It may be given by intramuscular or intravenous
injection in doses of 0.5g to 1.0g.
Precautions & Warning:
It contains Metamizole /Analgin which may cause agranulocytosts.
To be sold on prescription of registered medical practitioner only.
Store below 25℃. Protect from moisture. Keep out of reach of